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Introduction: Twenty four-hour ambulatory blood pressure monitoring is a clinically validated 
procedure in evaluation of blood pressure (BP). We hypothesised that the discomfort during 
cuff inﬂ  ation would increase the heart rate (HR) measured with 24-h ambulatory BP monitoring 
compared to a following HR measurement with a 24-h Holter monitor.
Methods: The study population (n = 56) were recruited from the outpatient’s clinic at 
the Department of Nephrology, Aalborg Hospital, Aarhus University Hospital at Aalborg, 
Denmark. All the patients had chronic kidney disease (CKD). We compared HR measured 
with a 24-h Holter monitor with a following HR measured by a 24-h ambulatory BP 
monitoring.
Results: We found a highly signiﬁ  cant correlation between the HR measured with the Holter 
monitor and HR measured with 24-h ambulatory blood pressure monitoring (r = 0.77, p   0.001). 
Using the Bland-Altman plot, the mean difference in HR was only 0.5 beat/min during 24 hours 
with acceptable limits of agreement for both high and low HR levels. Dividing the patients into 
groups according to betablocker treatment, body mass index, age, sex, angiotensin-converting 
enzyme inhibitor treatment, statins treatment, diuretic treatment, or calcium channel blocker 
treatment revealed similar results as described above.
Conclusion: The results indicate that the discomfort induced by cuff inﬂ  ation during 24-h 
ambulatory BP monitoring does not increase HR. Thus, 24-h ambulatory BP monitoring may 
be a reliable measurement of the BP among people with CKD.
Keywords: ambulatory blood pressure monitoring, Holter monitoring, heart rate, chronic 
kidney disease, hypertension
Introduction
Blood pressure (BP) measuring in a clinical environment is known to distress the 
patient causing a rise in BP, which makes the measured value higher than expected 
(Perloff et al 1983; Verdecchia et al 1994; Mancia et al 1997; Verdecchia et al 1997; 
Staessen et al 1999), a phenomenon referred to as “white-coat hypertension”. Thus, 
several studies have shown a 24-h ambulatory BP monitoring to be a more accurate 
predictor for cardiovascular disease than clinic BP, because 24-h ambulatory BP 
monitoring gives a truer value of the exact BP (Perloff et al 1983; Verdecchia 
et al 1994; Redon et al 1998; Staessen et al 1999; Imai 1999; Hansen et al 2006; 
Kazuo et al 2008).
However an elevation of BP might be induced by the discomfort the patient feels 
during cuff inﬂ  ation. This discomfort might materialize into an increased heart rate 
(HR) as well as BP (DeQuattro and Feng 2002). Conducting a 24-h HR from a 24-h 
ambulatory BP monitoring and subsequently measuring HR in 24 hours with a Holter 
monitor enabled us to compare the two differently measured HRs. Thus, the aim of 
this study was to evaluate HR during 24-h ambulatory BP monitoring compared to 
HR from a 24-h Holter monitoring.Integrated Blood Pressure Control 2008:1 16
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Methods
Study population
Patients (n = 64) were recruited from the outpatient’s clinic 
at the Department of Nephrology, Aalborg Hospital, Aarhus 
University Hospital (Table 1 shows the 56 patients who com-
pleted the study). Patients were eligible if they had chronic 
kidney disease (CKD) deﬁ  ned as plasma creatinine level 
between 1.70 and 4.53 mg/dL (150 and 400 μmol/L) for more 
than 3 months. Patients with nephrotic syndrome, malignant 
disease, uncontrollable hypertension, or a previous renal 
transplant were not asked to participate. Also, patients who 
had experienced myocardial infarction or underwent percuta-
neous coronary intervention or coronary artery bypass surgery 
during the previous last 6 months were not included.
The study population has previously been described 
(Svensson et al 2004).
HR from 24-h ambulatory BP monitoring was compared 
with HR from 24-h Holter readings. The 24-h ambulatory 
BP measurement was performed ﬁ  rst, followed by the Holter 
recording.
Twenty-four-hour ambulatory BP 
monitoring
Twenty-four-hour ambulatory BP monitoring was performed 
using an ambulatory BP device, TM 2412 (A&D Co Ltd, 
Tokyo, Japan). The BP was measured four times per hour 
during daytime (6 am–10 pm) and twice each hour during 
the night (10 pm–6 am). Recordings were included only if 
at least 75% of the readings were valid.
Holter monitoring
Holter-recordings were obtained in the study participants using 
a ﬂ  ash card 3-channel digital recorder with a sampling rate of 
128 Hz (Diagnostic Monitoring, Santa Ana, CA, USA). The 
recordings were started in the morning hours (7 am–10 am) 
when the patients attended the outpatient’s clinic and termi-
nated the following morning 24 hours later.
Statistics
Continuous data are reported as mean ± SD. P-values   0.05 
was considered statistically signiﬁ  cant. Comparison of groups 
was performed using nonpaired Student’s t-test for continuous 
variables. The Pearson’s correlation coefﬁ  cient was given for 
the correlation between the two measured HRs. The degree of 
agreement between the two HR parameters was assessed using 
the Bland–Altman analysis (Bland and Altman 1986).
Results
Fifty-six patients completed the study. Five left the study 
because of discomfort during the 24-h ambulatory BP 
monitoring. Three was excluded from the study because of 
technical problems with the Holter monitor.
Table 2 shows the mean HR measured with 24-h ambu-
latory BP monitoring and with 24-h Holter monitoring. No 
signiﬁ  cant differences were found between the HRs.
Figure 1A illustrates 24-hour HR measured dur-
ing 24-h ambulatory BP monitoring as a function of 
24-hour HR obtained from the Holter monitor. A highly 
significant correlation was found between these two 
indices (r = 0, 77, p   0.001). Figure 1B shows that 
the mean difference between the measured HRs was 
Table 2 Mean heart rate measured with both 24-h ambulatory 
blood pressure monitoring (BP) and with the Holter monitor in 
all the 56 patients and in subgroups of the patients
Mean heart Mean heart
rate BP rate Holter
All (n = 56) 73 ± 9 74 ± 10
Women (n = 16) 75 ± 10 74 ± 10
Men (n = 40) 73 ± 9 74 ± 10
Patients treated with:
Betablockers (n = 25) 68 ± 6 69 ± 8
Calcium channel blockers (n = 36) 71 ± 7 72 ± 9
Notes: No signiﬁ  cant differences were found. Values are expressed as means ± SD.
Table 1 Baseline characteristics of the 56 patients
Women (n) 16 (28%)
Men (n) 40 (71%)
Age (y) 58 ± 12
Body mass index (kg/m2) 28 ± 5
Smokers (n) 21 (38%)
Antihypertensive medication (n):
 β -blocker 25 (45%)
  Angiotensin-converting enzyme inhibitor 22 (39%)
  Calcium channel blocker 36 (64%)
 Diuretics 40  (71%)
   2 antihypertensives 45 (80%)
 Statins 7  (13%)
Type of renal disease (n):
 Glomerulonephritis 10  (18%)
  Chronic pyelonephritis 4 (7%)
  Polycystic kidney disease 7 (13%)
  Diabetic nephropathy 4 (7%)
 Hypertension 15  (15%)
 Other 16  (29%)
Note: The data are expressed as number of patients (%) or means ± SD.Integrated Blood Pressure Control 2008:1 17
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0.5 beats/min and their corresponding 95% limits of 
agreement was −13.0 to 12.0 beats/min. Only two outliers 
were observed.
Figure 2A illustrates the relationship between HR 
measured by 24-h ambulatory BP monitoring and the 
HR measured with the Holter monitor in patients treated 
with betablockers (r = 0.58, p   0.01). Figure 2B shows 
that the mean difference between the measured HRs 
was 0.5 beats/min and their corresponding 95% limits 
of agreement was −13.5 to 12.5 beats/min. One outlier 
was seen.
Figures 3A and 3B show similar relationships for patients 
not treated with betablockers (r = 0.80, p   0.001), and a 
mean difference in the measured HRs of 0.4 beats/min with 
limits of agreement from −10.6 to 11.4 beats/min. Two 
outliers were found.
100 90 80 70 60 50
25
20
15
10
5
0
–5
–10
–15
–20
[Pulse rate (Holter) – Pulse rate (BP)]/2
P
u
l
s
e
 
r
a
t
e
 
(
H
o
l
t
e
r
)
 
–
 
P
u
l
s
e
 
r
a
t
e
 
(
B
P
)
Beats/min
Beats/min
100 90 80 70 60 50
110
100
90
80
70
60
50
P
u
l
s
e
 
r
a
t
e
 
2
4
-
h
o
u
r
 
a
m
b
u
l
a
t
o
r
y
 
B
P
Beats/min
Beats/min
Pulse rate Holter
AB
Figure 1 A) Shows the heart rate measured with the Holter monitor as a function of the heart rate measured with 24-hour ambulatory BP monitoring in the 56 patients 
(r = 0.77, P < 0.001). B) Shows the Bland-Altman plot and indicates the mean heart difference (solid line) and 95% limits of agreement (dotted lines).
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Figure 2 A) Shows the heart rate measured with the Holter monitor as a function of the heart rate measured with 24-hour ambulatory BP monitoring in the 25 patients 
treated with betablockers (r = 0.58, P < 0.001). B) Shows the Bland-Altman plot and indicates the mean heart difference (= 0.50 beats/min)with dotted lines indicating 95% 
limits of agreement.Integrated Blood Pressure Control 2008:1 18
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Further dividing the patients into groups according to body 
mass index, age, sex, or treated with angiotensin-converting 
enzyme inhibitor, statins, diuretics or calcium channel 
blocker also revealed signiﬁ  cant correlations between the 
HRs and Bland–Altman plots comparable to the data given 
in the Figures (data not shown).
Discussion
This study showed a highly signiﬁ  cant correlation between 
HR measured with a Holter monitor and HR measured 
by 24-h ambulatory BP monitoring. Furthermore, the 
Bland–Altman plots revealed a low mean difference (= mean 
bias) of 0.5 beats/min between the two measured 24-h HRs. 
Furthermore, both high and low HR values were equally 
distributed around the mean difference line. This indicates 
that the possible discomfort induced when the cuff inﬂ  ates 
is of minor importance and does not change HR. Therefore, 
24-h ambulatory BP monitoring is expected to be a valid 
measurement of the true BP.
It is known that 24-h ambulatory BP monitoring is more 
closely related to target-organ damage of hypertension than 
the BP obtained by a physician in a clinical environment 
(Perloff et al 1983; Verdecchia et al 1994; Staessen et al 
1999; Hansen et al 2006; Kazuo et al 2008). Even though our 
results indicate that 24-h ambulatory BP monitoring is very 
reliable, the physician should be aware of the side effects 
when ordering the monitoring. Some patients feel discomfort 
wearing the monitor and some patients experience side 
effects such as pain, skin irritation, noise, inconvenience in 
relation to work, hematoma and sleep disturbances (Beltman 
et al 1996; Ernst and Bergus 2003). The indications for 24-h 
ambulatory BP monitoring could be suspected white-coat 
hypertension, treatment resistance, evaluation of BP control, 
and borderline hypertension (Ernst and Bergus 2003). The 
importance of educating the patients about the beneﬁ  ts of 
undergoing 24-h ambulatory BP monitoring has been dem-
onstrated (Ernst and Bergus 2003). The discomfort during 
the session may negatively inﬂ  uence their acceptance of 
undergoing the testing.
In the present study, the majority of patients were treated 
with antihypertensive drugs among these betablockers. 
Treatment with betablockers decreases HR and in addition 
inhibits the secretion of renin. In response cardiac output 
and the vascular resistance is lowered leading to a drop in 
BP. By inhibiting the sympathetic tone with betablockers, 
the triggered alerting reaction when the cuff inﬂ  ates is also 
inhibited. Considering this, it might be assumed that the 
group of patients treated with betablockers would have 
HRs measured by 24-h ambulatory BP monitoring, which 
deviates less from HRs measured by the Holter, compared 
to the group not treated with betablockers. However, we 
found a stronger correlation between the two HR values in 
patients without betablocking therapy compared to patients 
treated with betablockers but the Bland–Altman plots were 
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Figure 3 A) Shows the heart rate measured with the Holter monitor as a function of the heart rate measured with 24-hour ambulatory BP monitoring in the 25 patients 
treated with betablockers (r = 0.80, P < 0.001). B) Shows the Bland-Altman plot and the solid lines indicates the mean diffrerence (= 0.40 beats/min)with dotted lines indicating 
95% limits of agreement .Integrated Blood Pressure Control 2008:1 19
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quite similar. Thirty-six of the patients were treated with 
group II calcium channel blockers, which predominantly 
have an effect on arteries and veins leading to vasodilation. 
Unlike other calcium channel blockers these drugs do not 
affect the atrioventricular node and therefore, the calcium 
channel blockers used in this study were not expected to 
affect the measured HR-values.
Limitations
Twenty-four-hour ambulatory BP monitoring and Holter 
monitoring were performed on two successive weekdays. 
The best comparable measure of the HR would be obtained 
if the Holter monitoring and 24-h ambulatory BP moni-
toring were done simultaneously. However, the 24-hours 
mean value of the HR obtained by the Holter monitor 
would then contain HR-values measured while the cuff 
was inﬂ  ated.
In this study all the participants had CKD and it might 
be questioned whether the results are applicable to patients 
with essential arterial hypertension not receiving any medi-
cation yet.
Unfortunately, night and daytime were not discriminated 
by the Holter monitor and therefore we could not perform 
separate night and daytime analyses.
Conclusion
Our results showed that the HRs measured with 24-h Holter 
monitoring and 24-h ambulatory BP monitoring were quite 
similar. This indicates that the discomfort by the cuff inﬂ  ation 
does not increase HR in patients with CKD.
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